CTLA4 and myeloid sarcoma: Also, a CSF analysis of PPMS and RRMS patients for the expression of CTLA-4 on memory CD8+ T cells found substantial age-related variations in CTLA-4 expression pattern, with a tendency for it to decline in healthy controls while being entirely abrogated in MS patients.